| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.34 | 0.07 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.089 | 0.07 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.3 | 0.07 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.08 |